CIK 0001716166 · Non-accelerated filer<br>Smaller reporting company
Vivos Therapeutics, Inc.
Sign in to watch- Ticker
- VVOS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813224056
- Phone
- (866)908-4867
- Business address
- 7921 SOUTHPARK PLAZA,, SUITE 210, LITTLETON, CO, 80120
- Former names
- Vivos BioTechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-20 | SOKOLOW LEONARD J Director | Grant or award · Stock Option (Right to Buy) | +4,000 | $2.38 | $10K | 7,467 |
| 2024-06-20 | Lindsay Mark F. Director | Grant or award · Stock Option (Right to Buy) | +4,000 | $2.38 | $10K | 7,067 |
| 2024-06-20 | Krammer Anja B Director | Grant or award · Stock Option (Right to Buy) | +4,000 | $2.38 | $10K | 7,067 |
| 2024-06-20 | Huntsman Ronald Kirk Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | $2.38 | $48K | 49,334 |
| 2024-06-20 | Green Ralph Elias Director | Grant or award · Stock Option (Right to Buy) | +4,000 | $2.38 | $10K | 7,067 |
| 2024-06-20 | Amman Bradford K. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +15,000 | $2.38 | $36K | 31,667 |
| 2023-06-20 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +14,000 | $0.53 | $7K | 86,521 |
| 2023-06-16 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +10,000 | $0.54 | $5K | 67,521 |
| 2023-06-16 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +5,000 | $0.53 | $3K | 72,521 |
| 2023-06-15 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +21 | $0.50 | $11 | 57,521 |
| 2023-06-14 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +10,000 | $0.49 | $5K | 57,500 |
| 2022-12-23 | SOKOLOW LEONARD J Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $0.48 | $14K | 76,667 |
| 2022-12-23 | Krammer Anja B Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $0.48 | $14K | 76,667 |
| 2022-12-23 | Lindsay Mark F. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $0.48 | $14K | 76,667 |
| 2022-12-23 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +20,000 | $0.50 | $10K | 47,500 |
| 2022-12-23 | Huntsman Ronald Kirk Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +333,334 | $0.48 | $160K | 333,334 |
| 2022-12-23 | Huntsman Ronald Kirk Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | $0.48 | $72K | 483,334 |
| 2022-12-23 | Amman Bradford K. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | $0.48 | $96K | 500,001 |
| 2022-12-23 | Thompson Matthew Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $0.48 | $14K | 76,667 |
| 2022-12-23 | Green Ralph Elias Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $0.48 | $14K | 76,667 |
Page 2 of 4 · 62 trades